Mid Yorkshire Teaching NHS Trust

Specialist MDT: Mid Yorkshire Teaching NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling

Data Quality

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 469 469
Performance Status recorded 94% 94%
PSA completed 59% 59%
Gleason Score completed 85% 85%
TNM completed 78% 78%

Disease Presentation

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men with disease status determined 421 39897
Percentage of men diagnosed with metastatic disease 16% 17%

Management

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men diagnosed with low-risk localised disease 62 4684
Percentage of men with low-risk localised disease receiving radical treatment 4% 8%
No. of men diagnosed with locally advanced disease 169 15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment 69% 68%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023) 118
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 22%
No. of men who received radical prostatectomy (September 2020 - August 2021) 91
Adjusted percentage of men experiencing at least one GU complication (%) 12%

Compare provider outcomes